Myocardial β-adrenergic and muscarinic receptor density in cardiac pressure or volume overload

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 10, 1998, Pages 2095-2102

  Guzzetti, Stefano ^b   Mennini, Tiziana ^a   Cagnotto, Alfredo ^a   Di Biasi, Pietro ^c   Scrofani, Roberto ^c   Mezzetti, Silvia ^c   Cogliati, Chiara ^c   Paglia, Stefano ^c   Malliani, Alberto ^c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NONE

Author keywords

Aortic valve replacement; Muscarinic receptors; Receptor upregulation; adrenergic receptors

Indexed keywords

BETA ADRENERGIC RECEPTOR; MUSCARINIC RECEPTOR;

ADULT; AGED; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART HEMODYNAMICS; HEART VENTRICLE OVERLOAD; HUMAN; MALE; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

EID: 0032192288     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0773     Document Type: Article

References (42)

1. ARMOUR JA, 1991. Intrinsic cardiac neurons. J Cardiovasc Electrophysiol 2: 331-341.
2. BACMAN S, STERIN-BORDA L, CAMUSSO JJ, HUBSCHER O, ARANA R, BORDA ES, 1994. Circulating antibodies against neurotransmitter receptor activities in children with congenital heart block and their mothers. FASEB J 8: 1170-1176.
3. BEAU SL, TOLLEY TK, SAFFITZ JE, 1993. Heterogeneous transmural distribution of β-adrenergic receptor subtypes in failing human hearts. Circulation 88: 2501-2509.
4. BIEGON A, HANAU M, GREENBERGER V, SEGAL M, 1989. Aging and brain cholinergic muscarinic receptor subtypes: an autoradiographic study in the rat. Neurobiol Aging 10: 305-310.
5. ia in human hearts with dilated but not ischemic cardiomyopathy. Circulation 82: 1249-1265.
6. BOULOUX P, PERRETT D, BESSER GM, 1985. Methodological considerations in the determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection. Ann Clin Biochem 22: 190-203.
7. BRISTOW MR, GINSBURG R, MINOBE W, CUBICCIOTTI RS, SAGEMAN WS, LURIE K, BILLINGHAM ME, HARRISON DC, STINSON EB, 1982. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med 307: 205-211.
8. 1-receptor downregulation in heart failure. Circ Res 59: 297-309.
9. BRISTOW MR, ANDERSON FL, PORT JD, SKERL L, HERSHBERGER RE, LARRABEE P, O'CONNEL JB, RENLUND DG, VOLKMAN K, MURRAY J, FELDMAN AM, 1991. Differences in β-adrenergic neuroeffector mechanisms is ischemic versus idiopathic dilated cardiomyopathy. Circulation 84: 1024-1039.
10. BRISTOW MR, MINOBE W, RASMUSSEN R, LARRABEE P, SKEIL L, KLEIN JW, ANDERSON FL, MURRAY J, MESTRONI L, KARWANDE SV, FOWLER M, GINSBURG R, 1992. β-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest 89: 803-815.
11. 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. J Am Coll Cardiol 14: 323-331.
12. BUXTON BF, JONES CR, MOLENAAR P, SUMMERS RJ, 1987. Characterization and autoradiographic localization of β-adrenoceptor subtypes in human cardiac tissues. Br J Pharmac 92: 299-310.
13. CASTELLANO M, BOHM M, 1997. The cardiac β-adrenoceptor-mediated signaling pathway and its alterations in hypertensive heart disease. Hypertension 29: 715-722.
14. CHESTER MR, BARNETT DB, 1995. Cardiac chamber-specific β-adrenoceptor regulation and sympathetic innervation. Lancet 345: 553-555.
15. CHOUDHURY L, GUZZETTI S, LEFROY DC, NIHOYANNOPOULUS P, MCKENNA WJ, OAKLEY C, CAMICI PG, 1996. Myocardial β-adrenoceptors and left ventricular function in hypertrophic cardiomyopathy. Heart 75: 50-54.
16. DELEHANTI JM, HIMURA Y, ELAM H, HOOD WB, LIANG CS, 1994. β-adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content. Am J Physiol 266: H930-H935.
17. DENNIS AR, MARSH JD, QUIGG RJ, GORDON JB, COLUCCI WS, 1989. β-adrenergic receptor number and adnylate cyclase function in denervated transplanted and cardiomyopathic human hearts. Circulation 79: 1028-1034.
18. ECKBERG DL, DRABINSKY M, BRAUNWALD E, 1971. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 285: 877-883.
19. 2 adrenoceptors in the human atrioventricular conducting system: a comparison of patients with idiopathic dilated cardiomyopathy and ischemic heart disease. J Moll Cell Cardiol 26: 313-323.
20. FELDMAN AM, 1993. Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium. Circulation 87 (Suppl. IV): IV27-IV34.
21. FOWLER MB, LASER JA, HOPKINS GL, MINOBE W, BRISTOW MR, 1986. Assessment of the β-adrenergic receptor pathway in the intact failing human heart: progressive receptor downregulation and subsensitivity to agonist. Circulation 74: 1290-1302.
22. GUZZETTI S, COGLIATI C, PAGLIA S, MEZZETTI S, PORTA A, MALLIANI A, 1996. Changes induced by aortic valve replacement in cardiovascular neurohumoral control (Abstract). Circulation 94: 2924.
23. HAMMOND HK, WHITE FC, BRUNTON LL, LONGHURST JC, 1987. Association of decreased myocardial β-receptors and chronotropic response to isoproterenol and exercise in pigs following chronic dynamic exercise. Circ Res 60: 720-726.
24. HAMMOND HK, ROTH DA, INSEL PA, FORD CE, WHITE FC, MAISEL AS, ZIEGLER MG, BLOOR CM, 1992. Myocardial β-adrenergic receptor expression and signal transduction after chronic volume-overload hypertrophy and circulatory congestion. Circulation 85: 269-280.
25. HASKING GJ, ESLER MD, JENNINGS GL, BURTON B, JOHNS JA, KORNER PI, 1986. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73: 615-621.
26. HEILBRUNN SM, SHAH P, BRISTOW MR, VALANTINE HA, GINSBURG R, FOWLER MB, 1989. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 79: 483-490.
27. JOSEPH JA, ALGERI S, DE-CESARE A, COMUZIO M, ERAT S, KELLY J, CAGNOTTO A, MENNINI T, 1995. A reduced calorie-high fiber diet retards age-associated decreases in muscarinic receptor sensitivity. Neurobiol Aging 16: 607-612.
28. KIUCHI K, SHANNON RP, KONAMURA K, COHEN DJ, BIANCHI C, HOMCY CJ, VATNER SF, VATNER DE, 1993. Myocardial β-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest 91: 907-914.
29. LE GULUDEC D, COHEN-SOLAL A, DELFORGE J, DELAHAYE N, SYROTA A, MERLET P, 1997. Increased myocardial muscarinic receptor density in idiopathic dilated cardiomyopathy. Circulation 96: 3416-3422.
30. LIANG CS, FAN T-HM, SULLEBARGER JT, SAKAMOTO S, 1989. Decreased adrenergic neuronal uptake activity in experimental right heart failure: a chamber-specific contributor to β-adrenoceptor down-regulation. J Clin Invest 84: 1267-1275.
31. 11C CGP-12177 to assess β-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation 87: 1169-1178.
32. 2-adrenergic receptor. Science 264: 582-586.
33. MUNTZ KH, ZHAO M, MILLER JC, 1994. Downregulation of myocardial β-adrenergic receptors. Circ Res 74: 369-375.
34. MURPHREE SS, SAFFITZ JE, 1989. Distribution of β-adrenergic receptors in failing human myocardium. Implications for mechanisms of down-regulation. Circulation 79: 1214-1225.
35. NEVE KA, MCGONIGLE P, MOLINOFF PB, 1986. Quantitative analysis of the selectivity of radioligands for subtypes of β adrenergic receptors. J Pharmacol Exp Ther 238: 46-53.
36. PAKER M, 1992. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20: 248-254.
37. PETERSON GL, 1977. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Ann Biochem 83: 346-356.
38. 2 subtypes. J Cardiothorac Vasc Anesth 7: 668-673.
39. SWYNGHEDAUW B, 1991. Remodeling of the heart in chronic pressure overload. Basic Res Cardiol 86 (Suppl. I): 99-105.
40. VATNER DE, LEE DL, SCHWARZ KR, LONGABAUGH JP, FUJII AM, VATNER SF, HOMCY CJ, 1988. Impaired cardiac muscarinic receptor function in dogs with heart failure. J Clin Invest 81: 1836-1842.
41. WHITE M, RODEN R, MINOBE W, KHAN F, LARRABEE P, WOLLMERING M, PORT JD, ANDERSON F, CAMPBELL D, FELDMAN AM, BRISTOW MR, 1994. Age-related changes in β-adrenergic neuroeffector systems in the human heart. Circulation 90: 1225-1238.
42. YOSHIKAWA T, HANDA S, SUZUKI M, NAGAMI K, 1994. Abnormalities in sympathoneural regulation are localized to failing myocardium in rabbit heart. J Am Coll Cardiol 24: 210-215.